J. Fournier-Caruana

Facility-Associated Release of Polioviruses into Communities—Risks for the Posteradication Era

R. Sutter, J. Modlin, A. Bandyopadhyay, 2019, Emerging infectious diseases.

Off-label use of vaccines.

J. Hombach, G. Hanquet, Melanie Marti, 2017, Vaccine.

Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperatures.

Eric Stevens, W. Weldon, Dexiang Chen, 2018, Biologicals : journal of the International Association of Biological Standardization.

Progress Toward Containment of Poliovirus Type 2 — Worldwide, 2017

R. Sutter, M. Zaffran, Harpal Singh, 2017, MMWR. Morbidity and mortality weekly report.

Progress Toward Poliovirus Containment Implementation — Worldwide, 2017–2018

R. Sutter, M. Zaffran, Anna C. Llewellyn, 2018, MMWR. Morbidity and mortality weekly report.

Inactivated rabies vaccine control and release: use of an ELISA method.

C. Jallet, P. Perrin, N. Tordo, 2003, Biologicals : journal of the International Association of Biological Standardization.

Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio

L. Hampton, S. Shendale, L. Menning, 2017, The Journal of infectious diseases.

Assessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in Chad.

U. Kartoglu, G. Waeterloos, O. Ronveaux, 2011, Vaccine.

In vitro potency assay for yellow fever vaccines: comparison of three vero cell lines sources.

F. Fuchs, F. Garnier, J. Fournier-Caruana, 2000, Biologicals : journal of the International Association of Biological Standardization.